Report Code : CVMI2412246 | Published Date : March 3, 2025
The global allergy diagnostics market is undergoing a significant transformation, driven by the increasing prevalence of allergic disorders and advancements in diagnostic technologies. In 2024, the market is valued at 6.1 billion, with projections indicating it will reach 11.2 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.9%. This growth trajectory is supported by several key factors, including the rising incidence of food and respiratory allergies, the development of innovative diagnostic tools such as molecular testing and AI-powered platforms, and heightened healthcare spending in emerging economies.
ClearView Market Insights' comprehensive 250-page report offers an in-depth analysis of this dynamic market. The study provides a detailed examination of market size trends from 2021 through 2031, along with a thorough segmentation analysis by product type, allergen category, and end-user. Additionally, the report features a competitive landscape assessment, profiling major industry players and emerging disruptors shaping allergy diagnostics' future.
2. Market Overview and Key Findings
The allergy diagnostics sector has demonstrated consistent growth in recent years, with the market expanding from 4.5 billion in 2021 to 5.7 billion in 2023. This upward trend continues in 2024, with the market reaching USD6.1 billion, representing a 7.0% year-over-year increase. Looking ahead, the market is expected to maintain strong growth momentum, achieving an 8.9% CAGR through 2031.
Several notable trends are driving this expansion. Molecular allergy diagnostics has emerged as the fastest-growing segment, projected to grow at an impressive 14.2% CAGR. This growth is attributed to the technology's ability to provide more precise and comprehensive allergy profiles than traditional testing methods. Another significant development is the rising popularity of at-home testing kits, with companies like Everlywell and LetsGetChecked making allergy testing more accessible to consumers. Geographically, North America continues to dominate the market, accounting for 45% of global revenue, largely due to high healthcare expenditure and widespread adoption of advanced diagnostic technologies.
3. Market Segmentation Analysis
The allergy diagnostics market can be segmented by product type, allergen category, and end-user. Currently, immunoassay analyzers lead the product segment, generating USD 2.3 billion in revenue and capturing USD 382.3 billion in revenue (20% share), while ELISA tests and molecular diagnostics account for USD 1.0 billion and USD 161.0 billion (13%), respectively.
When examining allergen types, food allergens such as peanuts, milk, and shellfish constitute the largest category, making up 32% of the market. Inhalant allergens, including pollen and dust mites, account for 28% of the market. Regarding end-users, hospitals and clinics are the primary consumers of allergy diagnostics, representing 55% of the market, followed by diagnostic laboratories at 30%.
4. Competitive Landscape and Industry Innovations
The allergy diagnostics market features a combination of established corporations and innovative startups. Thermo Fisher Scientific retains its market leadership with a 25% share, primarily due to its ImmunoCAP system, which remains the gold standard in allergy testing. Siemens Healthineers follows with an 18% market share, while Danaher Corporation holds 12% through its Beckman Coulter diagnostics division.
Emerging companies are introducing disruptive technologies that are reshaping the industry. AllerScan is pioneering AI-driven allergy testing solutions that provide faster and more accurate results. Meanwhile, Clarityn's SmartTrack represents an innovative method for allergy monitoring utilizing wearable technology. These advancements are creating new opportunities for growth and competition within the sector.
5. Strategic Recommendations and Report Value
ClearView Market Insights' report provides stakeholders with vital data and analysis to navigate the evolving allergy diagnostics landscape. The study includes exclusive survey data collected from over 3,000 allergists worldwide, offering unique insights into testing preferences and technology adoption trends. Regulatory analysis covers the latest FDA and EMA approval patterns for novel diagnostics, assisting companies in anticipating and adapting to changing compliance requirements.
For investors and market entrants, the report highlights high-growth opportunities, especially in the Asia-Pacific region, where increasing healthcare expenditure and rising allergy prevalence are fueling demand for advanced diagnostic solutions. The detailed market forecasts and competitive analysis empower businesses to make informed strategic decisions and leverage emerging trends.
Reasons To Buy

Scope

Key Players
- Allergy Diagnostics Market – Thermo Fisher Scientific Inc.
- Siemens Healthineers
- Danaher Corporation
- HYCOR Biomedical
- bioMérieux SA
- Stallergenes Greer
- R-Biopharm AG
- Eurofins Scientific
- HOB Biotech Group
- INDOOR Biotechnologies Inc.
Global Allergy Diagnostics Market Report
- 1. Global Allergy Diagnostics Market Research Report
- 1.1 Study Objectives
- 1.2 Global Allergy Diagnostics Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2.1 Global Allergy Diagnostics Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Type
- 2.1.2 By Test Type
- 2.1.3 By Allergy Type
- 2.1.4 By End-user
- 2.1.5 By Region
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Type, By Test Type, By Allergy Type, By End-user, By Country
- 3.3. Opportunities – By Type, By Test Type, By Allergy Type, By End-user, By Country
- 3.4. Trends – By Type, By Test Type, By Allergy Type, By End-user, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Global Allergy Diagnostics Market Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.1 In-vitro Allergy Testing
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 In-vivo Allergy Testing
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Blood Tests
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Skin Tests
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Patch Tests
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Food Allergies
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Respiratory Allergies
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 Drug Allergies
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.4 Insect Sting Allergies
- 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 Hospitals
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2 Diagnostic Laboratories
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3 Home Care
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.4 Others.
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.1 North America
- 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.2 Europe
- 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.3 Asia-Pacific
- 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.4 Latin America
- 9.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.5 Middle East & Africa
- 9.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.6 Global Allergy Diagnostics Market - Opportunity Analysis Index, By Type, By Test Type, By Allergy Type, By End-user, and Region, 2024 - 2031
- 10.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 In-vitro Allergy Testing
- 10.1.2 In-vivo Allergy Testing
- 10.2.1 Blood Tests
- 10.2.2 Skin Tests
- 10.2.3 Patch Tests
- 10.3.1 Food Allergies
- 10.3.2 Respiratory Allergies
- 10.3.3 Drug Allergies
- 10.3.4 Insect Sting Allergies
- 10.4.1 Hospitals
- 10.4.2 Diagnostic Laboratories
- 10.4.3 Home Care
- 10.4.4 Others.
- 10.5.1 United States
- 10.5.2 Canada
10.7 Regional Trends Analysis
10.8 North America Global Allergy Diagnostics Market Research Report - Company Profiles- 10.8.1 Company 1 (United States)
- 10.8.2 Company 2 (Canada)
- 10.8.3 Company 3 (Canada)
- 11.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 In-vitro Allergy Testing
- 11.1.2 In-vivo Allergy Testing
- 11.2.1 Blood Tests
- 11.2.2 Skin Tests
- 11.2.3 Patch Tests
- 11.3.1 Food Allergies
- 11.3.2 Respiratory Allergies
- 11.3.3 Drug Allergies
- 11.3.4 Insect Sting Allergies
- 11.4.1 Hospitals
- 11.4.2 Diagnostic Laboratories
- 11.4.3 Home Care
- 11.4.4 Others.
- 11.5.1 Germany
- 11.5.2 United Kingdom
- 11.5.3 France
- 11.5.4 Spain
- 11.5.5 Italy
- 11.5.6 Russia
- 11.5.7 Netherlands
- 11.5.8 Poland
- 11.5.9 Rest of Europe
11.7 Regional Trends Analysis
11.8 Europe Global Allergy Diagnostics Market Research Report - Company Profiles- 11.8.1 Company 1 (Germany)
- 11.8.2 Company 2 (United Kingdom)
- 11.8.3 Company 3 (United Kingdom)
- 12.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 In-vitro Allergy Testing
- 12.1.2 In-vivo Allergy Testing
- 12.2.1 Blood Tests
- 12.2.2 Skin Tests
- 12.2.3 Patch Tests
- 12.3.1 Food Allergies
- 12.3.2 Respiratory Allergies
- 12.3.3 Drug Allergies
- 12.3.4 Insect Sting Allergies
- 12.4.1 Hospitals
- 12.4.2 Diagnostic Laboratories
- 12.4.3 Home Care
- 12.4.4 Others.
- 12.5.1 China
- 12.5.2 Japan
- 12.5.3 India
- 12.5.4 South Korea
- 12.5.5 Australia & NZ
- 12.5.6 ASEAN
- 12.5.7 Rest of Asia-Pacific
12.7 Regional Trends Analysis
12.8 Asia-Pacific Global Allergy Diagnostics Market Research Report - Company Profiles- 12.8.1 Company 1 (China)
- 12.8.2 Company 2 (Japan)
- 12.8.3 Company 3 (Japan)
- 13.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 In-vitro Allergy Testing
- 13.1.2 In-vivo Allergy Testing
- 13.2.1 Blood Tests
- 13.2.2 Skin Tests
- 13.2.3 Patch Tests
- 13.3.1 Food Allergies
- 13.3.2 Respiratory Allergies
- 13.3.3 Drug Allergies
- 13.3.4 Insect Sting Allergies
- 13.4.1 Hospitals
- 13.4.2 Diagnostic Laboratories
- 13.4.3 Home Care
- 13.4.4 Others.
- 13.5.1 Brazil
- 13.5.2 Mexico
- 13.5.3 Argentina
- 13.5.4 Peru
- 13.5.5 Colombia
- 13.5.6 Rest of Latin America
13.7 Regional Trends Analysis
13.8 Latin America Global Allergy Diagnostics Market Research Report - Company Profiles- 13.8.1 Company 1 (Brazil)
- 13.8.2 Company 2 (Mexico)
- 13.8.3 Company 3 (Mexico)
- 14.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 14.1.1 In-vitro Allergy Testing
- 14.1.2 In-vivo Allergy Testing
- 14.2.1 Blood Tests
- 14.2.2 Skin Tests
- 14.2.3 Patch Tests
- 14.3.1 Food Allergies
- 14.3.2 Respiratory Allergies
- 14.3.3 Drug Allergies
- 14.3.4 Insect Sting Allergies
- 14.4.1 Hospitals
- 14.4.2 Diagnostic Laboratories
- 14.4.3 Home Care
- 14.4.4 Others.
- 14.5.1 Saudi Arabia
- 14.5.2 UAE
- 14.5.3 South Africa
- 14.5.4 Egypt
- 14.5.5 Israel
- 14.5.6 Rest of Middle East and Africa
14.7 Regional Trends Analysis
14.8 Middle East & Africa Global Allergy Diagnostics Market Research Report - Company Profiles- 14.8.1 Company 1 (Saudi Arabia)
- 14.8.2 Company 2 (UAE)
- 14.8.3 Company 3 (UAE)
- 15.1 Strategic Dashboard of Top Market Players
15.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)- 15.2.1 Allergy Diagnostics Market – Thermo Fisher Scientific Inc.
- 15.2.2 Siemens Healthineers
- 15.2.3 Danaher Corporation
- 15.2.4 HYCOR Biomedical
- 15.2.5 bioMérieux SA
- 15.2.6 Stallergenes Greer
- 15.2.7 R-Biopharm AG
- 15.2.8 Eurofins Scientific
- 15.2.9 HOB Biotech Group
- 15.2.10 INDOOR Biotechnologies Inc.
17. Principal Presumptions and Acronyms